Pathogens (Nov 2021)

The Predictive Value of Mutation Screening for Anticipating COVID-19 Waves

  • Robert Hohan,
  • Petre Milu,
  • Simona Paraschiv,
  • Corina Casangiu,
  • Andreea Tudor,
  • Ovidiu Vlaicu,
  • Leontina Banica,
  • Marius Surleac,
  • Dragos Florea,
  • Dan Otelea

DOI
https://doi.org/10.3390/pathogens10111464
Journal volume & issue
Vol. 10, no. 11
p. 1464

Abstract

Read online

Emerging SARS-CoV-2 strains continue to generate difficulties for authorities and health care professionals worldwide due to enhanced transmissibility and/or immune response evasion. The appearance of the Alpha and Delta strains has been associated with substantial increases in the number of COVID-19 cases and associated deaths. Whole Genome Sequencing (WGS) continues to be the gold standard for molecular surveillance of the pandemics but other assays such as mutation genotyping can be used to reduce costs and allocated time. This study investigates the efficiency of mutation screening tests compared to WGS and their predictive value to anticipate future waves. A very high degree of fidelity for this type of assay was found, regardless of the method used. The positive predictive value (PPV) of 4/5 markers was over 95% for the detection of Alpha and Delta variants. By estimating the prevalence of the Alpha and Delta strains using genotyping assays and fitting the data to a mathematical model, a five week period between the point of exponential growth of variant prevalence and a drastic increase in case numbers was found. For that reason, raising awareness about the efficacy of mutation screening could help authorities adopt better measures in the future.

Keywords